AQST
- Aquestive Therapeutics, Inc.
()
Overview
Company Summary
Aquestive Therapeutics, Inc. (AQST) is a pharmaceutical company that specializes in the development and commercialization of innovative products to address unmet needs in neurology and other therapeutic areas. The company focuses on utilizing its proprietary technology platforms to develop orally-administered, fast-acting, and convenient medications.
One of Aquestive Therapeutics' core technologies is its PharmFilm� platform, which enables the delivery of pharmaceuticals through a dissolvable film that can be applied to the oral mucosa (inside the mouth). This delivery method offers several advantages over traditional oral dosage forms, such as improved medication absorption and increased patient compliance.
AQST develops and commercializes both branded and generic products. They have a diverse portfolio of products targeting various therapeutic areas, including central nervous system (CNS) disorders like epilepsy, migraine, and Parkinson's disease. The company's goal is to provide patients with better treatment options that are both effective and easier to use.
In addition to its own product development, Aquestive Therapeutics collaborates with pharmaceutical partners to enhance their existing medications using their proprietary technologies. By leveraging their expertise in oral film delivery, the company aims to improve the therapeutic outcomes and patient experience of existing drugs.
Overall, Aquestive Therapeutics is dedicated to advancing the field of drug delivery and improving patient care by developing innovative products that offer convenient, faster-acting, and potentially more effective treatment options in neurology and other therapeutic areas.